World Health Organization. Global hepatitis report 2024. https://www.who.int/publications/i/item/9789240091672 (2024).

Lampertico, P., Degasperi, E., Sandmann, L., Wedemeyer, H. & Delta Cure Working Group. Hepatitis D virus infection: pathophysiology, epidemiology and treatment. Report from the First International Delta Cure Meeting 2022. JHEP Rep. 5, 100818 (2023).

Article  PubMed  PubMed Central  Google Scholar 

Kramvis, A. et al. A roadmap for serum biomarkers for hepatitis B virus: current status and future outlook. Nat. Rev. Gastroenterol. Hepatol. 19, 727–745 (2022).

Article  PubMed  PubMed Central  Google Scholar 

Tsukuda, S. & Watashi, K. Hepatitis B virus biology and life cycle. Antivir. Res. 182, 104925 (2020).

Article  CAS  PubMed  Google Scholar 

Weng, M. K. et al. Universal hepatitis B vaccination in adults aged 19–59 years: updated recommendations of the advisory committee on immunization practices — United States, 2022. MMWR Morb. Mortal Wkly Rep. 71, 477–483 (2022).

Article  PubMed  PubMed Central  Google Scholar 

Yan, H. et al. Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus. eLife 1, e00049 (2012).

Article  PubMed  PubMed Central  Google Scholar 

Schaefer, S. Hepatitis B virus taxonomy and hepatitis B virus genotypes. World J. Gastroenterol. 13, 14–21 (2007).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu, H. et al. Cryo-EM structures of human hepatitis B and woodchuck hepatitis virus small spherical subviral particles. Sci. Adv. 8, eabo4184 (2022).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Abou-Jaoude, G. & Sureau, C. Entry of hepatitis delta virus requires the conserved cysteine residues of the hepatitis B virus envelope protein antigenic loop and is blocked by inhibitors of thiol-disulfide exchange. J. Virol. 81, 13057–13066 (2007).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Salisse, J. & Sureau, C. A function essential to viral entry underlies the hepatitis B virus ‘a’ determinant. J. Virol. 83, 9321–9328 (2009).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Seitz, S. et al. A slow maturation process renders hepatitis B virus infectious. Cell Host Microbe 20, 25–35 (2016).

Article  CAS  PubMed  Google Scholar 

Gudima, S., Meier, A., Dunbrack, R., Taylor, J. & Bruss, V. Two potentially important elements of the hepatitis B virus large envelope protein are dispensable for the infectivity of hepatitis delta virus. J. Virol. 81, 4343–4347 (2007).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Le Seyec, J., Chouteau, P., Cannie, I., Guguen-Guillouzo, C. & Gripon, P. Role of the pre-S2 domain of the large envelope protein in hepatitis B virus assembly and infectivity. J. Virol. 72, 5573–5578 (1998).

Article  PubMed  PubMed Central  Google Scholar 

Lepere, C., Regeard, M., Le Seyec, J. & Gripon, P. The translocation motif of hepatitis B virus envelope proteins is dispensable for infectivity. J. Virol. 81, 7816–7818 (2007).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Barrera, A., Guerra, B., Notvall, L. & Lanford, R. E. Mapping of the hepatitis B virus pre-S1 domain involved in receptor recognition. J. Virol. 79, 9786–9798 (2005).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Glebe, D. et al. Mapping of the hepatitis B virus attachment site by use of infection-inhibiting preS1 lipopeptides and tupaia hepatocytes. Gastroenterology 129, 234–245 (2005).

Article  CAS  PubMed  Google Scholar 

Gripon, P., Cannie, I. & Urban, S. Efficient inhibition of hepatitis B virus infection by acylated peptides derived from the large viral surface protein. J. Virol. 79, 1613–1622 (2005).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Perez-Vargas, J. et al. A fusion peptide in preS1 and the human protein disulfide isomerase ERp57 are involved in hepatitis B virus membrane fusion process. eLife 10, e64507 (2021).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Leistner, C. M., Gruen-Bernhard, S. & Glebe, D. Role of glycosaminoglycans for binding and infection of hepatitis B virus. Cell Microbiol. 10, 122–133 (2008).

CAS  PubMed  Google Scholar 

Schulze, A., Gripon, P. & Urban, S. Hepatitis B virus infection initiates with a large surface protein-dependent binding to heparan sulfate proteoglycans. Hepatology 46, 1759–1768 (2007).

Article  CAS  PubMed  Google Scholar 

Sureau, C. & Salisse, J. A conformational heparan sulfate binding site essential to infectivity overlaps with the conserved hepatitis B virus a-determinant. Hepatology 57, 985–994 (2013).

Article  CAS  PubMed  Google Scholar 

Verrier, E. R. et al. A targeted functional RNA interference screen uncovers glypican 5 as an entry factor for hepatitis B and D viruses. Hepatology 63, 35–48 (2016).

Article  CAS  PubMed  Google Scholar 

Iwamoto, M. et al. Evaluation and identification of hepatitis B virus entry inhibitors using HepG2 cells overexpressing a membrane transporter NTCP. Biochem. Biophys. Res. Commun. 443, 808–813 (2014).

Article  CAS  PubMed  Google Scholar 

Ni, Y. et al. Hepatitis B and D viruses exploit sodium taurocholate co-transporting polypeptide for species-specific entry into hepatocytes. Gastroenterology 146, 1070–1083 (2014).

Article  CAS  PubMed  Google Scholar 

Gad, S. A. et al. The kinesin KIF4 mediates HBV/HDV entry through the regulation of surface NTCP localization and can be targeted by RXR agonists in vitro. PLoS Pathog. 18, e1009983 (2022).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hu, Q. et al. E-cadherin plays a role in hepatitis B virus entry through affecting glycosylated sodium-taurocholate cotransporting polypeptide distribution. Front. Cell. Infect. Microbiol. 10, 74 (2020).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Macovei, A. et al. Hepatitis B virus requires intact caveolin-1 function for productive infection in HepaRG cells. J. Virol. 84, 243–253 (2010).

Article  CAS  PubMed  Google Scholar 

Herrscher, C. et al. Hepatitis B virus entry into HepG2-NTCP cells requires clathrin-mediated endocytosis. Cell Microbiol. 22, e13205 (2020).

Article  CAS  PubMed  Google Scholar 

Huang, H. C., Chen, C. C., Chang, W. C., Tao, M. H. & Huang, C. Entry of hepatitis B virus into immortalized human primary hepatocytes by clathrin-dependent endocytosis. J. Virol. 86, 9443–9453 (2012).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Umetsu, T. et al. Inhibitory effect of silibinin on hepatitis B virus entry. Biochem. Biophys. Rep. 14, 20–25 (2018).

PubMed  PubMed Central  Google Scholar 

Fauzyah, Y. et al. Ponesimod suppresses hepatitis B virus infection by inhibiting endosome maturation. Antivir. Res. 186, 104999 (2021).

Article